LMISX
Price
$27.49
Change
-$0.14 (-0.51%)
Updated
Oct 7 closing price
Net Assets
401.5M
VITSX
Price
$160.49
Change
-$0.76 (-0.47%)
Updated
Oct 7 closing price
Net Assets
2.02T
Interact to see
Advertisement

LMISX vs VITSX

Header iconLMISX vs VITSX Comparison
Open Charts LMISX vs VITSXBanner chart's image
Franklin U.S. Large Cap Equity IS
Price$27.49
Change-$0.14 (-0.51%)
VolumeN/A
Net Assets401.5M
Vanguard Total Stock Market Idx I
Price$160.49
Change-$0.76 (-0.47%)
VolumeN/A
Net Assets2.02T
LMISX vs VITSX Comparison Chart in %
View a ticker or compare two or three
VS
LMISX vs. VITSX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMISX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 2.02T vs. LMISX (401M). VITSX pays higher dividends than LMISX: VITSX (1.14) vs LMISX (0.36). LMISX was incepted earlier than VITSX: LMISX (17 years) vs VITSX (28 years). LMISX (0.79) is less costly to investors than VITSX (0.03). LMISX is a more actively managed with annual turnover of: 49.00 vs. VITSX (2.00). LMISX has a lower initial minimum investment than VITSX: LMISX (1000000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 18.36 vs. LMISX (15.68). VITSX return over 5 years is better than : 89.10 vs. LMISX (52.09).
LMISXVITSXLMISX / VITSX
Total Expense Ratio0.700.032,333%
Annual Report Gross Expense Ratio0.790.032,633%
Fund Existence17 years28 years-
Gain YTD13.61014.39895%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets401M2.02T0%
Annual Yield % from dividends0.361.1432%
Returns for 1 year15.6818.3685%
Returns for 3 years75.9582.1292%
Returns for 5 years52.0989.1058%
Returns for 10 years77.15231.7633%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRIAX35.25N/A
N/A
Principal Glb Emerging Markets A
ETCHX37.00N/A
N/A
Eventide Healthcare & Life Sciences C
LICTX18.46N/A
N/A
Lord Abbett International Equity R5
VVJEX11.89N/A
N/A
Voya VACS Series MCV Fund
GFFFX88.40-0.57
-0.64%
American Funds Growth Fund of Amer F2